These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 29986452)
21. Novel functionalization strategies of polymeric nanoparticles as carriers for brain medications. Portioli C; Bovi M; Benati D; Donini M; Perduca M; Romeo A; Dusi S; Monaco HL; Bentivoglio M J Biomed Mater Res A; 2017 Mar; 105(3):847-858. PubMed ID: 27885823 [TBL] [Abstract][Full Text] [Related]
22. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile. Rafiei P; Haddadi A Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163 [TBL] [Abstract][Full Text] [Related]
23. Blended nanoparticle system based on miscible structurally similar polymers: a safe, simple, targeted, and surprisingly high efficiency vehicle for cancer therapy. Tao W; Zhang J; Zeng X; Liu D; Liu G; Zhu X; Liu Y; Yu Q; Huang L; Mei L Adv Healthc Mater; 2015 Jun; 4(8):1203-14. PubMed ID: 25800699 [TBL] [Abstract][Full Text] [Related]
24. Transferrin functionalized chitosan-PEG nanoparticles for targeted delivery of paclitaxel to cancer cells. Nag M; Gajbhiye V; Kesharwani P; Jain NK Colloids Surf B Biointerfaces; 2016 Dec; 148():363-370. PubMed ID: 27632697 [TBL] [Abstract][Full Text] [Related]
25. The brain targeting mechanism of Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles. Xin H; Sha X; Jiang X; Chen L; Law K; Gu J; Chen Y; Wang X; Fang X Biomaterials; 2012 Feb; 33(5):1673-81. PubMed ID: 22133551 [TBL] [Abstract][Full Text] [Related]
26. Dual targeted polymeric nanoparticles based on tumor endothelium and tumor cells for enhanced antitumor drug delivery. Gupta M; Chashoo G; Sharma PR; Saxena AK; Gupta PN; Agrawal GP; Vyas SP Mol Pharm; 2014 Mar; 11(3):697-715. PubMed ID: 24512060 [TBL] [Abstract][Full Text] [Related]
27. Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma. Xin H; Jiang X; Gu J; Sha X; Chen L; Law K; Chen Y; Wang X; Jiang Y; Fang X Biomaterials; 2011 Jun; 32(18):4293-305. PubMed ID: 21427009 [TBL] [Abstract][Full Text] [Related]
28. New approach to treating spinal cord injury using PEG-TAT-modified, cyclosporine-A-loaded PLGA/polymeric liposomes. Gao SJ; Liu Y; Wang HJ; Ban DX; Cheng SZ; Ning GZ; Wang LL; Chang J; Feng SQ J Drug Target; 2017 Jan; 25(1):75-82. PubMed ID: 27250819 [TBL] [Abstract][Full Text] [Related]
29. Transferrin-appended PEGylated nanoparticles for temozolomide delivery to brain: in vitro characterisation. Jain A; Chasoo G; Singh SK; Saxena AK; Jain SK J Microencapsul; 2011; 28(1):21-8. PubMed ID: 21171813 [TBL] [Abstract][Full Text] [Related]
30. Targeting nevirapine delivery across human brain microvascular endothelial cells using transferrin-grafted poly(lactide-co-glycolide) nanoparticles. Kuo YC; Lin PI; Wang CC Nanomedicine (Lond); 2011 Aug; 6(6):1011-26. PubMed ID: 21707298 [TBL] [Abstract][Full Text] [Related]
31. Nanomedicine strategy for optimizing delivery to outer hair cells by surface-modified poly(lactic/glycolic acid) nanoparticles with hydrophilic molecules. Wen X; Ding S; Cai H; Wang J; Wen L; Yang F; Chen G Int J Nanomedicine; 2016; 11():5959-5969. PubMed ID: 27877041 [TBL] [Abstract][Full Text] [Related]
32. Nanoparticle transport across in vitro olfactory cell monolayers. Gartziandia O; Egusquiaguirre SP; Bianco J; Pedraz JL; Igartua M; Hernandez RM; Préat V; Beloqui A Int J Pharm; 2016 Feb; 499(1-2):81-89. PubMed ID: 26721725 [TBL] [Abstract][Full Text] [Related]
33. PEG-PLA block copolymer as potential drug carrier: preparation and characterization. Ben-Shabat S; Kumar N; Domb AJ Macromol Biosci; 2006 Dec; 6(12):1019-25. PubMed ID: 17128420 [TBL] [Abstract][Full Text] [Related]
34. [Transport of PLGA nanoparticles across Caco-2/HT29-MTX co-cultured cells]. Wen Z; Li G; Lin DH; Wang JT; Qin LF; Guo GP Yao Xue Xue Bao; 2013 Dec; 48(12):1829-35. PubMed ID: 24689242 [TBL] [Abstract][Full Text] [Related]
35. PEGylation strategies for active targeting of PLA/PLGA nanoparticles. Betancourt T; Byrne JD; Sunaryo N; Crowder SW; Kadapakkam M; Patel S; Casciato S; Brannon-Peppas L J Biomed Mater Res A; 2009 Oct; 91(1):263-76. PubMed ID: 18980197 [TBL] [Abstract][Full Text] [Related]
36. Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood-brain barrier. Chang J; Jallouli Y; Kroubi M; Yuan XB; Feng W; Kang CS; Pu PY; Betbeder D Int J Pharm; 2009 Sep; 379(2):285-92. PubMed ID: 19416749 [TBL] [Abstract][Full Text] [Related]
37. Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature. Yu DH; Lu Q; Xie J; Fang C; Chen HZ Biomaterials; 2010 Mar; 31(8):2278-92. PubMed ID: 20053444 [TBL] [Abstract][Full Text] [Related]
38. PLGA nanoparticles prepared by nano-emulsion templating using low-energy methods as efficient nanocarriers for drug delivery across the blood-brain barrier. Fornaguera C; Dols-Perez A; Calderó G; García-Celma MJ; Camarasa J; Solans C J Control Release; 2015 Aug; 211():134-43. PubMed ID: 26057857 [TBL] [Abstract][Full Text] [Related]
39. Shuttle-mediated nanoparticle transport across an in vitro brain endothelium under flow conditions. Falanga AP; Pitingolo G; Celentano M; Cosentino A; Melone P; Vecchione R; Guarnieri D; Netti PA Biotechnol Bioeng; 2017 May; 114(5):1087-1095. PubMed ID: 27861732 [TBL] [Abstract][Full Text] [Related]
40. Investigation on mechanisms of glycopeptide nanoparticles for drug delivery across the blood-brain barrier. Tosi G; Fano RA; Bondioli L; Badiali L; Benassi R; Rivasi F; Ruozi B; Forni F; Vandelli MA Nanomedicine (Lond); 2011 Apr; 6(3):423-36. PubMed ID: 21542682 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]